Life Sciences

Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation

With strong policies in place to protect confidential information, the company was able to take swift action against an employee after becoming aware of suspicious activity

Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation
“Every crisis brings about innovation" – how the vaccine race is transforming biopharma IP
24 Nov 2021

“Every crisis brings about innovation" – how the vaccine race is transforming biopharma IP

From greater respect for researchers to a fresh focus on compulsory licences, IAM’s Global Leaders share their views on how the life sciences space has been changed by the quest for covid-19 vaccines

How to deal with China's new crackdown on bad-faith patent filings and other examination changes
24 Nov 2021

How to deal with China's new crackdown on bad-faith patent filings and other examination changes

The Long Read: New guidelines in the works at the CNIPA will continue the fight against 'irregular' applications, make utility models harder to get and heighten the risk of litigation in the software space, write Aaron Wininger of Schwegman Lundberg & Woessner, PA and Austin Chang of Beijing East IP

Latest

View all
23 Nov 2021

Novo Nordisk’s $3.3 billion Dicerna purchase shows booming RNA IP market

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly Read more

19 Nov 2021

Why CNIPA could be the go-to venue for Chinese patent linkage plaintiffs

Pharma patentees face difficult choices under the country’s new early dispute resolution framework Read more

18 Nov 2021

Nobel laureate’s troubles are a cautionary tale about the importance of university tech-transfer support

Tasuku Honjo’s recent patent battles highlight the potential IP dangers of academic collaborations Read more

16 Nov 2021

Patent suits decline in Dusseldorf and Mannheim, but Munich’s docket is on the rise

Germany is Europe’s biggest and most active litigation forum, but subtle differences in case law and proceedings mean that plaintiffs have important choices to make about where to file their suits Read more

News

View all
11 Sep 2021

The DABUS decision makes Australia look like a champion of innovation, not a chump

Saturday Opinion: Federal Court's AI inventorship decision should serve as a clarion call for Australia to lead on innovation issues Read more

25 Aug 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other practice areas - becomes a Law Business Research company Read more

14 Jul 2021

Arthrex could offer life sciences patents extra layer of protection

Co-published - An additional level of scrutiny for IPR decisions will be a boon for owners of valuable pharma and biotech patents Read more

26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world Read more

Analysis

View all
16 Nov 2021

Four things to watch as China’s first patent linkage litigation is filed

Beijing IP Court lawsuit launched by Japan’s Chugai Pharmaceutical will be inaugural test of the new system, and possible procedural issues are already appearing Read more

12 Nov 2021

A multi-million-dollar patent damages win for J&J in China is good news for foreign rights holders

US company’s subsidiary secures major award against a local infringer at the Supreme People’s Court Read more

11 Nov 2021

Moderna on IP collision course with US government

The company is at loggerheads with National Institutes of Health over inventorship of crucial covid vaccine technology Read more

9 Nov 2021

Dim prospects for industry 101 compromise as US Congress looks at eligibility once more

People involved in previous reform efforts say that passing any legislation will be tough as stakeholders are still years away from agreement Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more